HAARMANN Partnerschaftsgesellschaft
HAARMANN Partnerschaftsgesellschaft: Dual Listing – Oasmia trusts in HAARMANN with regard to its dual listing
HAARMANN Partnerschaftsgesellschaft / Key word(s): Enterprise/ Dual Listing: Oasmia trusts in HAARMANN with regard to its dual listing Oasmia Pharmaceutical AB, a company active in the pharmaceutical sector, has been admitted to the regulated market of Frankfurt Stock Exchange; first day of trading is 24 January 2011 Oasmia Pharmaceutical AB with its registered business seat in Uppsala, Sweden, has been approved to the regulated market NASDAQ OMX of the stock exchange in Stockholm since June 2010. For the purpose of broadening its investors’ basis, Oasmia Pharmaceutical AB has conducted a dual listing to the regulated market of Frankfurt Stock Exchange. Oasmia Pharmaceutical AB develops innovative active pharmaceutical ingredients in the sectors human and veterinary oncology on nanotechnologic basis. The company expects final approvals of several active pharmaceutical ingredients in 2011 and 2012. Oasmia Pharmaceutical AB will be the first Swedish company listed in the regulated market of Frankfurt Stock Exchange. The company has deliberately decided in favour of the regulated market and against the open market in order to guarantee the highest possible degree of transparency vis-à-vis its investors. During the process of dual listing which was without precedent regarding a Swedish company Oasmia Pharmaceutical AB had been advised legally by HAARMANN and capital market related by Silvia Quandt & Cie. AG together with biw Bank für Investments und Wertpapiere AG and Autenrieth Capital GmbH & Co. KG. Advisors Oasmia Pharmaceutical AB: HAARMANN Partnerschaftsgesellschaft: Robert Bastian (Corporate/Capital Markets) Bird & Bird (Stockholm): Hans Svensson, Staffan Seger (Associate) Silvia Quandt & Cie. AG: Robin Huber, Sebastian Wagner biw Bank für Investments und Wertpapiere AG: Alexander Caron Autenrieth Capital GmbH & Co. KG: Nicola R. Facciorusso Robert Bastian HAARMANN Partnerschaftsgesellschaft Rechtsanwälte Steuerberater Wirtschaftsprüfer Neue Mainzer Straße 75 60311 Frankfurt am Main Tel.: +49-69-92059-850 Fax: +49-69-92059-990 Mobil: +49-172-6617845 E-Mail: robert.bastian@haarmann.com End of Media Release 24.01.2011 Dissemination of a Press Release, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
109838 24.01.2011 |